ADPT
#1621
Adaptive Biotechnologies Corporation - Common Stock
21.0 2 USD
0.00%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-0.19%
Variación mensual
+14.36%
Variación en los últimos 6 meses
+15.81%
Cambio anual
+21.78%
Cierres anteriores
21.0 6
Open
21.0 2
Mínimo
21.0 2
High
21.0 2
Volumen
135
Financials
- Market Capitalization 3.36 B
- Employee 624
- Founded 2009
- CEO Chad Robins
- Website www.adaptivebiotech.com
- Headquarter Washington, United States
- FIGI BBG001J2PFF5
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
-41.64
Relación precio/flujo de caja
8.9
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1614 |  ARQT Arcutis Biotherapeutics, Inc. - Common stock | 27.12 USD | -2.24% | +3.12% | +10.15% | +70.14% | 3.39 B USD | ||
| 1617 |  DYN Dyne Therapeutics, Inc. - Common Stock | 23.64 USD | +0.94% | +3.68% | +28.06% | +0.98% | 3.38 B USD | ||
| 1641 |  RARE Ultragenyx Pharmaceutical Inc. - Common Stock | 33.22 USD | -1.77% | -7.54% | +34.93% | +13.22% | 3.27 B USD | ||
| 1661 |  BEAM Beam Therapeutics Inc. - Common Stock | 31.00 USD | -5.14% | -15.07% | +3.85% | +45.27% | 3.19 B USD |